Anticoccidial Drugs Global Market Report 2025

Description

Anticoccidial drugs constitute a category of medications employed in the prevention and treatment of coccidiosis, an intestinal parasitic ailment induced by protozoa from the genus Eimeria. These medications function by impeding diverse stages of the coccidia life cycle, thereby managing the infection and averting the consequential intestinal harm and associated symptoms. Widely utilized in veterinary practice, especially in poultry, these drugs contribute to bolstering health and productivity by addressing this prevalent and economically impactful condition.

The primary categories of anticoccidial drugs encompass ionophores, antibiotics, sulphonamides, chemical derivatives, and others. Ionophores, for instance, intervene in the proliferation and propagation of coccidia parasites by modulating ion movement across cellular membranes. These drugs exhibit varied actions, serving both coccidiostatic and coccidiocidal purposes across diverse applications such as poultry, swine, fish, cattle, and companion animals. They are distributed through various channels, including veterinary hospitals, retail pharmacies, among others.

The anticoccidial drugs market research report is one of a series of new reports from The Business Research Company that provides anticoccidial drugs market statistics, including anticoccidial drugs industry global market size, regional shares, competitors with a anticoccidial drugs market share, detailed anticoccidial drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anticoccidial drugs industry. This anticoccidial drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anticoccidial drugs market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased incidence of coccidiosis globally, increased adoption of pet animals, high prevalence of coccidiosis, economic impact, and increased safety concerns about food and health of animals.

The anticoccidial drugs market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the growing number of veterinary healthcare, the rising prevalence of coccidiosis in animals, the increasing use of synthetic drugs, the growing demand for feed additives, and increasing livestock production. Major trends in the forecast period include the surge in demand driven by emerging coccidiosis strains, a shift towards natural and alternative treatment methods, increased regulatory scrutiny prompting innovation, rising consumer preferences for antibiotic-free poultry products, advancements in drug delivery technologies, heightened focus on preventive healthcare measures, and expanding applications in aquaculture and companion animal sectors.

The increasing demand for meat proteins is expected to drive the growth of the anticoccidial drug market in the coming years. Meat proteins, which are naturally found in animal flesh, consist of various essential amino acids that play a crucial role in bodily functions. This rising demand for meat proteins is driven by factors such as population growth, higher disposable income, urbanization, and changing dietary preferences toward protein-rich foods. Anticoccidial drugs are critical in modern livestock farming, as they help maintain animal health and productivity, allowing farmers to meet the growing demand for meat proteins in a sustainable and efficient manner. For example, a report published in July 2023 by the Organization for Economic Co-operation and Development (OECD) and the Food and Agriculture Organization (FAO) noted that while global average per capita meat demand is expected to rise by 2% from the 2020-2022 base period to 2032, the FAO meat price index increased by 10% in 2022 due to lower export supplies. As a result, the growing demand for meat proteins is fueling the expansion of the anticoccidial drug market.

The upsurge in poultry farming is poised to drive the advancement of the anticoccidial drug market in the coming years. Poultry farming involves the rearing of domesticated avian species such as chickens, turkeys, ducks, and geese for the production of meat, eggs, and feathers. This increase in poultry farming is attributed to a growing demand for protein, enhancements in farming methodologies, and the expansion of global trade. Anticoccidial drugs are commonly administered to poultry either through feed or water as a preemptive measure to shield the birds from coccidiosis during their initial and most susceptible growth stages. For instance, as reported by the USDA Economic Research Service in June 2023, total sales in the poultry sector soared to $76.9 billion in 2022, marking a notable 67% surge from the preceding year. Hence, the surge in poultry farming acts as a catalyst for the burgeoning growth of the anticoccidial drug market.

Leading companies in the anticoccidial drugs market are focusing on developing innovative solutions, such as synthetic coccidiostats, to improve efficacy, reduce resistance development, and address emerging challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound used to prevent or control coccidiosis by inhibiting the growth and reproduction of coccidia parasites in animals. For example, in March 2023, Zoetis, a US-based animal health company, introduced Avi-Deccox, a reformulated synthetic coccidiostat designed to control coccidiosis in broiler chickens. This product targets the pathogens Eimeria acervulina and Eimeria tenella, which cause significant economic losses in poultry farming. Featuring decoquinate as its active ingredient, similar to its predecessor, Deccox, Avi-Deccox addresses the growing issue of resistance linked to the frequent use of ionophores in poultry farming by utilizing a different mode of action, offering a more effective short-term knockdown effect.

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc, Bayer AG, Novartis AG, Eli Lilly and Company Ltd, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Sante Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc, Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anticoccidial drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The anticoccidial drugs market consist of sales of monensin, semduramicin, lasalocid, decoquinate, salinomycin, amprolium, clopidol, and sulfachloropyrazine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anticoccidial Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anticoccidial drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anticoccidial drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anticoccidial drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Ionophore; Antibiotic; Sulphonamides; Chemical Derivative; Other Drug Classes
2) By Drug Action: Coccidiostatic; Coccidiocidal
3) By Application: Poultry; Swine; Fish; Cattle; Companion Animals
4) By Distribution Channel: Veterinary Hospitals; Retail Pharmacy; Other Distribution Channels
Subsegments:
1) By Ionophore: Monensin; Lasalocid; Salinomycin
2) By Antibiotic: Tylosin; Lincomycin; Bacitracin
3) By Sulphonamides: Sulfadimethoxine; Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril; Clopidol
5) By Other Drug Classes: Amprolium; Robenidine
Companies Mentioned: Johnson & Johnson; Merck and Co. Inc; Bayer AG; Novartis AG; Eli Lilly and Company Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29413

1. Executive Summary

2. Anticoccidial Drugs Market Characteristics

3. Anticoccidial Drugs Market Trends And Strategies

4. Anticoccidial Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Anticoccidial Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Anticoccidial Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Anticoccidial Drugs Market Growth Rate Analysis
5.4. Global Anticoccidial Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Anticoccidial Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Anticoccidial Drugs Total Addressable Market (TAM)

6. Anticoccidial Drugs Market Segmentation

6.1. Global Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ionophore
Antibiotic
Sulphonamides
Chemical Derivative
Other Drug Classes
6.2. Global Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coccidiostatic
Coccidiocidal
6.3. Global Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Poultry
Swine
Fish
Cattle
Companion Animals
6.4. Global Anticoccidial Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals
Retail Pharmacy
Other Distribution Channels
6.5. Global Anticoccidial Drugs Market, Sub-Segmentation Of Ionophore, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monensin
Lasalocid
Salinomycin
6.6. Global Anticoccidial Drugs Market, Sub-Segmentation Of Antibiotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tylosin
Lincomycin
Bacitracin
6.7. Global Anticoccidial Drugs Market, Sub-Segmentation Of Sulphonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sulfadimethoxine
Sulfaquinoxaline
6.8. Global Anticoccidial Drugs Market, Sub-Segmentation Of Chemical Derivative, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diclazuril
Clopidol
6.9. Global Anticoccidial Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amprolium
Robenidine

7. Anticoccidial Drugs Market Regional And Country Analysis

7.1. Global Anticoccidial Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Anticoccidial Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anticoccidial Drugs Market

8.1. Asia-Pacific Anticoccidial Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anticoccidial Drugs Market

9.1. China Anticoccidial Drugs Market Overview
9.2. China Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anticoccidial Drugs Market

10.1. India Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anticoccidial Drugs Market

11.1. Japan Anticoccidial Drugs Market Overview
11.2. Japan Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anticoccidial Drugs Market

12.1. Australia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anticoccidial Drugs Market

13.1. Indonesia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anticoccidial Drugs Market

14.1. South Korea Anticoccidial Drugs Market Overview
14.2. South Korea Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anticoccidial Drugs Market

15.1. Western Europe Anticoccidial Drugs Market Overview
15.2. Western Europe Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anticoccidial Drugs Market

16.1. UK Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anticoccidial Drugs Market

17.1. Germany Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anticoccidial Drugs Market

18.1. France Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anticoccidial Drugs Market

19.1. Italy Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anticoccidial Drugs Market

20.1. Spain Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anticoccidial Drugs Market

21.1. Eastern Europe Anticoccidial Drugs Market Overview
21.2. Eastern Europe Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anticoccidial Drugs Market

22.1. Russia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anticoccidial Drugs Market

23.1. North America Anticoccidial Drugs Market Overview
23.2. North America Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anticoccidial Drugs Market

24.1. USA Anticoccidial Drugs Market Overview
24.2. USA Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anticoccidial Drugs Market

25.1. Canada Anticoccidial Drugs Market Overview
25.2. Canada Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anticoccidial Drugs Market

26.1. South America Anticoccidial Drugs Market Overview
26.2. South America Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anticoccidial Drugs Market

27.1. Brazil Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anticoccidial Drugs Market

28.1. Middle East Anticoccidial Drugs Market Overview
28.2. Middle East Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anticoccidial Drugs Market

29.1. Africa Anticoccidial Drugs Market Overview
29.2. Africa Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anticoccidial Drugs Market Competitive Landscape And Company Profiles

30.1. Anticoccidial Drugs Market Competitive Landscape
30.2. Anticoccidial Drugs Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eli Lilly and Company Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Anticoccidial Drugs Market Other Major And Innovative Companies

31.1. Boehringer Ingelheim GmbH
31.2. Zoetis Inc.
31.3. Elanco Animal Health Incorporated
31.4. Intas Pharmaceuticals Ltd.
31.5. Ceva Sante Animale S.A.
31.6. Virbac S.A.
31.7. Phibro Animal Health Corporation
31.8. Vetoquinol SA
31.9. Alpharma BVBA
31.10. Kepro B.V.
31.11. Kemin Industries Inc.
31.12. Tianjin Ringpu Bio-Technology Co. Ltd.
31.13. Hester Biosciences Limited
31.14. Huvepharma AD
31.15. Biovet S.A.

32. Global Anticoccidial Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anticoccidial Drugs Market

34. Recent Developments In The Anticoccidial Drugs Market

35. Anticoccidial Drugs Market High Potential Countries, Segments and Strategies

35.1 Anticoccidial Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Anticoccidial Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Anticoccidial Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer